151751-Najiba-Chargi

86 CHAPTER 5 REFERENCES 1. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing . 2019;48(1):16-31. doi:10.1093/ageing/ afy169 2. Yang M, Shen Y, Tan L, Li W. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis. Chest . 2019;156(1):101-111. doi:10.1016/j. chest.2019.04.115 3. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur J Cancer . 2016;57:58- 67. doi:10.1016/j.ejca.2015.12.030 4. Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer . 2019;22(1):10-22. doi:10.1007/s10120-018- 0882-2 5. Mintziras I, Miligkos M, Wächter S, Manoha - ran J, Maurer E, Bartsch DK. Sarcopenia and sarcopenic obesity are significantly associ- ated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis. Int J Surg . 2018;59:19- 26. doi:10.1016/j.ijsu.2018.09.014 6. Boshier PR, Heneghan R, Markar SR, Bara - cos VE, Low DE. Assessment of body com - position and sarcopenia in patients with esophageal cancer: A systematic reviewand meta-analysis. Dis Esophagus . 2018;31(8). doi:10.1093/dote/doy047 7. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol . 2017;71:26-33. doi:10.1016/j.oraloncology.2017.05.012 8. Bril SI, Pezier TF, Tijink BM, Janssen LM, Braunius WW, Bree R. Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy. Head Neck . 2019;41(6):1745- 1755. doi:10.1002/hed.25638 9. Ansari E, Chargi N, van Gemert JTM, et al. Low skeletal muscle mass is a strong pre- dictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap. Oral Oncol . 2020;101. doi:10.1016/j.oraloncology.2019.104530 10. Chargi N, Bril SI, Swartz JE, Wegner I, Wil - lems SW, de Bree R. Skeletal muscle mass is an imaging biomarker for decreased sur- vival in patients with oropharyngeal squa- mous cell carcinoma. Oral Oncol . 2020;101. doi:10.1016/j.oraloncology.2019.104519 11. Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Oto-Rhi- no-Laryngology . 2019;276(5):1475-1486. doi:10.1007/s00405-019-05361-4 12. Findlay M, White K, Lai M, Luo D, Bauer JD. The Association Between Computed Tomography–Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review. J Acad Nutr Diet . 2020;120(8):1330-1347.e8. doi:10.1016/j.jand.2020.03.021 13. Wong A, Zhu D, Kraus D, Tham T. Radiolog - ically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope . March 2020. doi:10.1002/ lary.28616 14. Lin SC, Lin YS, Kang BH, et al. Sarcope - nia results in poor survival rates in oral cavity cancer patients. Clin Otolaryngol . 2020;45(3):327-333. doi:10.1111/coa.13481